Coloplast A/S (COLO-B.CO) Stock Analysis & Winston Score
Coloplast is a Danish medical device company that makes products for people with intimate health conditions — things like ostomy bags (for people who have had bowel surgery), catheters, wound care dressings, and continence products. Its customers are mostly patients, hospitals, and home care providers across the world. Coloplast is one of the largest companies in the world focused specifically on ostomy and continence care. The company sells its products directly to healthcare systems and through distributors, earning revenue from ongoing product purchases rather than one-time sales — patients typically need these supplies every day for life. Coloplast operates in over 40 countries, with Europe as its largest market, though it has been growing in the United States and emerging markets. Its main competitive advantages are strong brand loyalty among patients and clinicians and deep specialization in a niche that larger medical device companies tend to ignore. The key growth risk is pricing pressure from healthcare systems looking to cut costs on consumable medical supplies.
Winston Score: 52/100 — Average
Mixed quality — meaningful strengths and weaknesses.
- Quality: Good (15/30)
- Growth: Weak (3/20)
- Cash Flow: Exceptional (10/10)
- Stability: Good (5/10)
- Valuation: Good (5/10)
- Ownership: Good (10/15)
Key Facts
Price: 437.50 DKK
Market Cap: 98.6B DKK
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Exchange: NASDAQ Copenhagen



